Biphenyl

Biphenyl

SCHEMBL1400697

CCOC(N)=O.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.62
TSHR P16473 1/20 0.50
ALDH1A1 P00352 7/20 0.49
MAPT P10636 6/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
HPGD P15428 5/20 0.49
KDM4E B2RXH2 4/20 0.49
RAB9A P51151 4/20 0.49
NPSR1 Q6W5P4 3/20 0.49
GAA P10253 3/20 0.49
NPC1 O15118 2/20 0.49
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
PKM P14618 1/20 0.48
HSD17B10 Q99714 5/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
GRM6 O15303 2/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL9312116 0.96 ALOX15 (0.58) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
Toluene SCHEMBL7177102 0.88 ALOX15 (0.62) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
Urethane SCHEMBL2404606 0.87 ALOX15 (0.83) ALOX15TSHRALDH1A1SMN1; SMN2NPSR1
Phenol SCHEMBL9506782 0.86 ALOX15 (0.60) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
Aniline SCHEMBL27371840 0.86 ALOX15 (0.60) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
Phenol SCHEMBL1348208 0.86 ALOX15 (0.60) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
Biphenyl SCHEMBL9485868 0.85 ALOX15 (0.46) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
Biphenyl SCHEMBL10948129 0.85 ALOX15 (0.46) ALOX15ALDH1A1MAPTSMN1; SMN2HPGD
Urethane SCHEMBL6557515 0.85 ALOX15 (0.65) ALOX15TSHRALDH1A1MAPTSMN1; SMN2
O-Xylene SCHEMBL10812881 0.85 ALOX15 (0.65) ALOX15TSHRALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5549987-A Polyurethane based electrolytes for electrochemical cells and electrochemical cells using same MOTOROLA, INC. (US) 1996-08-27 US claimed
EP-0374067-A1 Method for making a sling or a load lifting strap in which the web of cable strands in covered with a polyurethane elastomer CABLERIES D'ALSACE ET DE LORRAINE, S.A. (FR) 1990-06-20 EP claimed
WO-2025133985-A1 ADHESIVE ARTICLE RELEASE LAYERS COMPRISING DIPHENYL URETHANE COMPOUND 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-06-26 WO disclosed
EP-3044190-B1 BURN RATE MODIFIER THALES AUSTRALIA LTD (AU) 2024-07-03 EP disclosed
EP-3254800-B1 FLUX ACTIVATING AGENT, FLUX, AND SOLDER KOKI KK (JP) 2020-11-11 EP disclosed
US-10702956-B2 Flux activator, flux, and solder KOKI COMPANY LIMITED (JP) 2020-07-07 US disclosed
EP-3044191-B1 BURN RATE MODIFIER THALES AUSTRALIA LTD (AU) 2019-11-20 EP disclosed
US-20190210938-A1 PROPELLANT STABILIZER THALES AUSTRALIA LIMITED (AU) 2019-07-11 US disclosed
US-10196323-B2 Burn rate modifier THALES AUSTRALIA LIMITED (AU) 2019-02-05 US disclosed
US-10087116-B2 Burn rate modifier THALES AUSTRALIA LIMITED (AU) 2018-10-02 US disclosed
US-20180015576-A1 Flux Activator, Flux, and Solder KOKI COMPANY LIMITED (JP) 2018-01-18 US disclosed
US-20020134269-A1 Temperature-independent propellant powder NITROCHEMIE ASCHAU GMBH (DE) 2002-09-26 US disclosed
US-20020121321-A1 Gas-generating compositions NOF CORPORATION (JP) 2002-09-05 US disclosed
EP-1142853-A1 GAS GENERATOR COMPOSITION NOF CORPORATION (JP) 2001-10-10 EP disclosed
US-6066200-A COMPRISING A SOLID UREA COMPOUND, AN ALCOHOL, A LIGHTFASTNESS COMPONENT, A LIGHTFAST ANTIOXIDANT, AND A COLORANT XEROX CORPORATION (US) 2000-05-23 US disclosed
EP-0891312-A4 MATERIALS HAVING HIGH ELECTRICAL CONDUCTIVITY AT ROOM TEMPERATURES AND METHODS FOR MAKING SAME ROOM TEMPERATURE SUPERCONDUCTO (US) 1999-05-06 EP disclosed
EP-0891312-A1 MATERIALS HAVING HIGH ELECTRICAL CONDUCTIVITY AT ROOM TEMPERATURES AND METHODS FOR MAKING SAME Room Temperature Superconductors Inc. (US) 1999-01-20 EP disclosed
WO-1997028107-A1 MATERIALS HAVING HIGH ELECTRICAL CONDUCTIVITY AT ROOM TEMPERATURES AND METHODS FOR MAKING SAME ROOM TEMPERATURE SUPERCONDUCTORS INC. (US) 1997-08-07 WO disclosed
US-4085090-A Aromatic polymers containing a nitrogen-containing ring group, and process for preparation thereof TEIJIN LIMITED (JA) 1978-04-18 US disclosed
US-4085268-A Disubstituted s-triazines ARMSTRONG CORK COMPANY (US) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10702956-B2 Flux activator, flux, and solder FOXO1, NCOA1, AHR ALOX15 2937/4885TSHR 313/4885ALDH1A1 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.